These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 17005398

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intermittent inotrope infusion for end stage heart failure in Duchenne muscular dystrophy.
    van Baalen A, von Spiczak S, Stephani U, Fischer G.
    Neuromuscul Disord; 2008 Dec; 18(12):1005-6; author reply 1006. PubMed ID: 18952428
    [No Abstract] [Full Text] [Related]

  • 3. A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home.
    Brozena SC, Twomey C, Goldberg LR, Desai SS, Drachman B, Kao A, Popjes E, Zimmer R, Jessup M.
    J Heart Lung Transplant; 2004 Sep; 23(9):1082-6. PubMed ID: 15454175
    [Abstract] [Full Text] [Related]

  • 4. Dobutamine-related asthma in a patient awaiting cardiac transplantation: the eosinophilic dilemma.
    Aranda JM, Woo G, Pauly DF, Rodriguez E, Hill JA, Schofield RS.
    J Heart Lung Transplant; 2004 Feb; 23(2):260-1. PubMed ID: 14761776
    [Abstract] [Full Text] [Related]

  • 5. [Effective milrinone therapy to a Duchenne muscular dystrophy patient with advanced congestive heart failure].
    Matsumura T, Saito T, Miyai I, Nozaki S, Kang J.
    Rinsho Shinkeigaku; 1999 Jun; 39(6):643-8. PubMed ID: 10502990
    [Abstract] [Full Text] [Related]

  • 6. Home inotropic therapy in children.
    Berg AM, Snell L, Mahle WT.
    J Heart Lung Transplant; 2007 May; 26(5):453-7. PubMed ID: 17449413
    [Abstract] [Full Text] [Related]

  • 7. Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure.
    Upadya S, Lee FA, Saldarriaga C, Verma S, Sedrakyan A, Nystrom K, Katz SD.
    J Heart Lung Transplant; 2004 Apr; 23(4):466-72. PubMed ID: 15063407
    [Abstract] [Full Text] [Related]

  • 8. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
    Gorodeski EZ, Chu EC, Reese JR, Shishehbor MH, Hsich E, Starling RC.
    Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Continuous Intravenous Milrinone Therapy in Pediatric Outpatients.
    Curley M, Liebers J, Maynard R.
    J Infus Nurs; 2017 Jul; 40(2):92-96. PubMed ID: 28248808
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
    Barraud D, Faivre V, Damy T, Welschbillig S, Gayat E, Heymes C, Payen D, Shah AM, Mebazaa A.
    Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
    [Abstract] [Full Text] [Related]

  • 14. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S, Warfield KT, Wood CM, Miller WL.
    Am J Cardiol; 2006 Dec 15; 98(12):1627-30. PubMed ID: 17145223
    [Abstract] [Full Text] [Related]

  • 15. [Infusion of inotropic agents at home in patients with severe heart failure: an important role for the nurse practitioner].
    Ypenburg C, Verwey HF, van der Wall EE.
    Ned Tijdschr Geneeskd; 2007 Nov 03; 151(44):2426-8. PubMed ID: 18064859
    [Abstract] [Full Text] [Related]

  • 16. Outpatient dobutamine for end-stage congestive heart failure.
    Miller LW, Merkle EJ, Herrmann V.
    Crit Care Med; 1990 Jan 03; 18(1 Pt 2):S30-3. PubMed ID: 2293976
    [Abstract] [Full Text] [Related]

  • 17. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes.
    Bayram M, De Luca L, Massie MB, Gheorghiade M.
    Am J Cardiol; 2005 Sep 19; 96(6A):47G-58G. PubMed ID: 16181823
    [Abstract] [Full Text] [Related]

  • 18. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
    Drakos SG, Kanakakis JV, Nanas S, Bonios M, Kaldara E, Katsaros F, Pantsios C, Nanas JN.
    J Cardiovasc Pharmacol; 2009 Feb 19; 53(2):157-61. PubMed ID: 19188832
    [Abstract] [Full Text] [Related]

  • 19. Should we use outpatient dobutamine or milrinone?
    Kato M, Sanada S, Kitakaze M.
    Circ Heart Fail; 2009 Jul 19; 2(4):377-8. PubMed ID: 19808362
    [No Abstract] [Full Text] [Related]

  • 20. Outpatient parenteral inotropic therapy for advanced heart failure.
    Young JB, Moen EK.
    J Heart Lung Transplant; 2000 Aug 19; 19(8 Suppl):S49-57. PubMed ID: 11016488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.